BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27593958)

  • 1. Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches.
    Basith S; Cui M; Macalino SJY; Choi S
    Curr Med Chem; 2017; 24(42):4753-4778. PubMed ID: 27593958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Biology Aspects of Computational Methods & Applications in Drug Discovery.
    Chien ST; Kumar A; Pandey S; Yen CK; Wang SY; Wen ZH; Kaushik AC; Shiue YL; Pan CT
    Curr Pharm Des; 2018; 24(32):3758-3766. PubMed ID: 30417777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process.
    Del Carmen Quintal Bojórquez N; Campos MRS
    Curr Cancer Drug Targets; 2023; 23(5):333-345. PubMed ID: 35792126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
    Hameed R; Khan A; Khan S; Perveen S
    Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery.
    Razia IT; Kanwal A; Riaz HF; Malik A; Ahsan M; Khan MS; Raza A; Sabir S; Sajid Z; Khan MF; Tahir RA; Sehgal SA
    Curr Top Med Chem; 2023; 23(30):2844-2862. PubMed ID: 38031798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combating Diseases with Computational Strategies Used for Drug Design and Discovery.
    Makhouri FR; Ghasemi JB
    Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current topics in computer-aided drug design.
    Taft CA; Da Silva VB; Da Silva CH
    J Pharm Sci; 2008 Mar; 97(3):1089-98. PubMed ID: 18214973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Studies in Drug Design Against Cancer.
    De B; Bhandari K; Mendonça FJB; Scotti MT; Scotti L
    Anticancer Agents Med Chem; 2019; 19(5):587-591. PubMed ID: 30207247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review.
    Chua HM; Moshawih S; Kifli N; Goh HP; Ming LC
    PLoS One; 2024; 19(5):e0301396. PubMed ID: 38776291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.
    Usha T; Shanmugarajan D; Goyal AK; Kumar CS; Middha SK
    Curr Top Med Chem; 2017; 17(30):3296-3307. PubMed ID: 29295698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational drug repositioning for cancer therapeutics.
    Jiao M; Liu G; Xue Y; Ding C
    Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and ligand-based design of P-glycoprotein inhibitors: a historical perspective.
    Palmeira A; Sousa E; Vasconcelos MH; Pinto M; Fernandes MX
    Curr Pharm Des; 2012; 18(27):4197-214. PubMed ID: 22827485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of computational methods for anticancer drug discovery, design, and optimization.
    Prada-Gracia D; Huerta-Yépez S; Moreno-Vargas LM
    Bol Med Hosp Infant Mex; 2016; 73(6):411-423. PubMed ID: 29421286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
    Hasan MR; Alsaiari AA; Fakhurji BZ; Molla MHR; Asseri AH; Sumon MAA; Park MN; Ahammad F; Kim B
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current insights into computer-aided immunotherapeutic design strategies.
    Cai Z; Zhang G; Zhang X; Liu Y; Fu X
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.